These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8080607)

  • 1. Dot-ELISA for seroepidemiological study of exposure to Shigella flexneri.
    Suthienkul O; Poomchart A; Kositanont U; Siripanichgon K; Vathanophas K
    Asian Pac J Allergy Immunol; 1993 Dec; 11(2):141-7. PubMed ID: 8080607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISA for seroepidemiological study of exposure to Vibrio cholerae of population in Krabi Province, Thailand.
    Suthienkul O; Poomchart A; Kositanont U; Siripanichgon K; Vathanophas K
    Asian Pac J Allergy Immunol; 1992 Jun; 10(1):55-60. PubMed ID: 1418185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R
    PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.
    Robin G; Cohen D; Orr N; Markus I; Slepon R; Ashkenazi S; Keisari Y
    J Infect Dis; 1997 May; 175(5):1128-33. PubMed ID: 9129076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution.
    Bangtrakulnonth A; Vieira AR; Lo Fo Wong DM; Pornreongwong S; Pulsrikarn C; Sawanpanyalert P; Hendriksen RS; Aarestrup FM
    Foodborne Pathog Dis; 2008 Dec; 5(6):773-84. PubMed ID: 19086804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to plasmid-encoded antigens in children and adults with shigellosis.
    Echeverria P; Hanchalay S; Taylor DN
    Diagn Microbiol Infect Dis; 1988 Jun; 10(2):75-80. PubMed ID: 3066570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent acquisition of IgG antibodies to
    Kapulu MC; Muthumbi E; Otieno E; Rossi O; Ferruzzi P; Necchi F; Acquaviva A; Martin LB; Orindi B; Mwai K; Kibet H; Mwanzu A; Bigogo GM; Verani JR; Mbae C; Nyundo C; Agoti CN; Nakakana UN; Conti V; Bejon P; Kariuki S; Scott JAG; Micoli F; Podda A
    Front Immunol; 2024; 15():1340425. PubMed ID: 38361949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations.
    Van de Verg LL; Herrington DA; Boslego J; Lindberg AA; Levine MM
    J Infect Dis; 1992 Jul; 166(1):158-61. PubMed ID: 1607690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF
    Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
    [No Abstract]   [Full Text] [Related]  

  • 12. Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.
    Lindberg AA; Cam PD; Chan N; Phu LK; Trach DD; Lindberg G; Karlsson K; Kärnell A; Ekwall E
    Rev Infect Dis; 1991; 13 Suppl 4():S231-7. PubMed ID: 2047643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor C3 conversion in human complement by smooth Shigella flexneri lipopolysaccharides.
    Fudała R; Doroszkiewicz W; Niedbach J; Gamian A; Weintraub A; Kaca W
    Acta Microbiol Pol; 2003; 52(1):45-52. PubMed ID: 12916727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Escherichia coli and Shigella flexneri in milk from undernourished mothers: studies on sodium dodecyl sulfate-polyacrylamide gel electrophoresis-separated antigens.
    Herías MV; Mattsby-Baltzer I; Cruz JR; Hanson LA
    Pediatr Res; 1997 Nov; 42(5):644-50. PubMed ID: 9357938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diarrheal disease among caregivers at children's day-care centers. A retrospective and seroepidemiologic study].
    Koton S; Cohen D; Green MS
    Harefuah; 1999 Jan; 136(2):97-101, 176. PubMed ID: 10914170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related prevalence of Shigella and Salmonella antibodies and their association with diarrhoeal diseases in Peruvian children.
    Nguyen BM; Lanata CF; Black RE; Gil AI; Kärnell A; Wretlind B
    Scand J Infect Dis; 1998; 30(2):159-64. PubMed ID: 9730303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the diagnosis of dysentery in adults by determining antibodies to Shigella in the saliva].
    Kolesnikova EN; Gennad'eva TIa; Khazenson LB
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):20-6. PubMed ID: 352063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
    Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
    APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.